Cangjie Yang

Associate Director Zipcode Bio

Cangjie Yang is an Associate Director in Zipcode Bio, with a focus on carrier design for nucleic acid therapeutics across diverse disease indications. His current work centers on developing simplified, single-component delivery systems to enable programmable biodistribution of nucleic acids across multiple organs. Previously, he was an Associate Director at CSL Seqirus, leading lipid nanoparticle (LNP) platform development for samRNA vaccines and gene therapy programs. He has led ionizable lipid and formulation development efforts, integrating molecular design with formulation optimization and scale-up considerations to advance delivery platforms from early discovery through IND-enabling development

Seminars

Thursday 1st October 2026
Panel Discussion: Scaling LNP Workflows from Discovery to GMP and Beyond: Bridging Throughput, Robustness & Commercial Readiness
1:40 pm

Key questions include:

  • How are teams successfully translating high-throughput, discovery-stage LNP workflows into robust, GMP-ready processes without compromising product quality?
  • Where do current LNP workflows break when moving from preclinical into clinical and commercial scale – and how can these gaps be addressed early?
  • What needs to change today to ensure LNP platforms remain scalable, reproducible, and cost-effective as products move toward global commercial supply?
Cangjie Yang speaker for 5th mRNA Process Development & CMC Summit